Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine

CONTEXT: Many differentiated thyroid cancers (DTC) dedifferentiate and become radioactive iodine (RAI)–refractory (RAIR) with worse outcomes. Targeted therapy (TTx) may downregulate MAPK signaling and sensitize tumors to RAI. OBJECTIVE: We describe patients with RAIR DTC receiving TTx with demonstra...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Endocrinol Metab
Главные авторы: Jaber, Tania, Waguespack, Steven G, Cabanillas, Maria E, Elbanan, Mohamed, Vu, Thinh, Dadu, Ramona, Sherman, Steven I, Amit, Moran, Santos, Elmer B, Zafereo, Mark, Busaidy, Naifa L
Формат: Artigo
Язык:Inglês
Опубликовано: Endocrine Society 2018
Предметы:
Clinical Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6179172/
https://ncbi.nlm.nih.gov/pubmed/30032208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-00612
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы